In 2023, the R&D budget for health and medical sciences in France stood at X% of the total government support. From 2024 to 2028, there is a slight increase forecasted in this budget as a percentage of government support, with stability observed in certain years. The year-on-year variance is minimal, indicating a cautious and steady commitment toward health R&D. The five-year CAGR reflects stability with a slight upward trajectory.

Future trends to watch for:

Potential policy shifts in government priorities impacting funding allocations.
Increased focus on innovative technologies such as AI in healthcare might necessitate higher R&D investments.
Global health challenges could influence future budgetary adjustments to respond to emerging needs.